358 related articles for article (PubMed ID: 19781403)
1. Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
Köster R; Kaehler J; Meinertz T;
Am Heart J; 2009 Oct; 158(4):e51-7. PubMed ID: 19781403
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
Tendera M; Borer JS; Tardif JC
Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
Borer JS; Tardif JC
Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
López-Bescós L; Filipova S; Martos R
Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
[TBL] [Abstract][Full Text] [Related]
5. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
6. Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
Koester R; Kaehler J; Ebelt H; Soeffker G; Werdan K; Meinertz T
Clin Res Cardiol; 2010 Oct; 99(10):665-72. PubMed ID: 20454968
[TBL] [Abstract][Full Text] [Related]
7. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
Prasad UK; Gray D; Purcell H
Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
Perings S; Stöckl G; Kelm M;
Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
[TBL] [Abstract][Full Text] [Related]
9. Ivabradine: pharmacodynamic aspects of its clinical use.
Stieber J
Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
[TBL] [Abstract][Full Text] [Related]
10. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Borer JS; Le Heuzey JY
Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
[TBL] [Abstract][Full Text] [Related]
12. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
[TBL] [Abstract][Full Text] [Related]
13. Rate control with ivabradine: angina pectoris and beyond.
Parakh N; Bhargava B
Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
[TBL] [Abstract][Full Text] [Related]
14. Ivabradine: new drug. Best avoided in stable angina.
Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine for the treatment of stable angina pectoris in octogenarians.
Koester R; Kaehler J; Meinertz T
Clin Res Cardiol; 2011 Feb; 100(2):121-8. PubMed ID: 20821016
[TBL] [Abstract][Full Text] [Related]
17. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Werdan K; Ebelt H; Nuding S; Höpfner F; Hack G; Müller-Werdan U
Clin Res Cardiol; 2012 May; 101(5):365-73. PubMed ID: 22231643
[TBL] [Abstract][Full Text] [Related]
18. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
[TBL] [Abstract][Full Text] [Related]
19. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Tardif JC; Ponikowski P; Kahan T;
Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
Cappato R; Castelvecchio S; Ricci C; Bianco E; Vitali-Serdoz L; Gnecchi-Ruscone T; Pittalis M; De Ambroggi L; Baruscotti M; Gaeta M; Furlanello F; Di Francesco D; Lupo PP
J Am Coll Cardiol; 2012 Oct; 60(15):1323-9. PubMed ID: 22981555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]